CVS Health Corporation
|Deal Type||Debt Capital Markets|
|Client & Transactional Partners||CVS Health Corporation||Our Role||Co-Manager|
On August 16, 2019, CVS Health Corporation priced $3.5 billion of Senior Notes in three tranches:
- 1.0 billion of Senior Notes due 2024
- $750 million of Senior Notes due 2026
- $1.75 billion of Senior Notes due 2029
The Company plans to use net proceeds from the offering to fund certain cash tender offers, with any remaining proceeds to be used for general corporate purposes.
KeyBanc Capital Markets acted as Co-Manager on the transaction.